BCWM
ABBV icon

Ball & Co Wealth Management’s AbbVie ABBV Stock Holding History

Ball & Co Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
2,272
+19
+0.8% +$4.09K 0.4% 17
2026
Q1 		$490K Buy
2,253
+16
+0.7% +$3.55K 0.41% 15
2025
Q4 		$511K Sell
2,237
-34
-1% -$7.75K 0.33% 22
2025
Q3 		$525K Buy
2,271
+18
+0.8% +$3.67K 0.35% 20
2025
Q2 		$418K Buy
2,253
+20
+0.9% +$3.72K 0.45% 14
2025
Q1 		$467K Buy
2,233
+19
+0.9% +$3.69K 0.5% 14
2024
Q4 		$393K Buy
+2,214
New +$407K 0.31% 14

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ball & Co Wealth Management's ABBV Position: Q2 2026 in Review

Ball & Co Wealth Management increased its AbbVie (ABBV) stake by 0.84% in Q2 2026, buying an estimated $4.09K and bringing the position to 2,272 shares worth $571K. The position accounts for 0.4% of the portfolio, ranked #17.

Ball & Co Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ball & Co Wealth Management held 2,272 shares of AbbVie worth $571K as of Q2 2026.
  • Ball & Co Wealth Management bought 19 AbbVie shares in Q2 2026, an estimated $4.09K.
  • AbbVie made up 0.4% of Ball & Co Wealth Management's portfolio in Q2 2026, its #17 holding.
  • Ball & Co Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ball & Co Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.